Your Survivorship Care Plan After Immunotherapy — What Goes In It, and Who Writes It

What Should a Survivorship Care Plan After Immunotherapy Contain?

Two halves: what was given, and what still gets watched. The backward half names the drug, the number of cycles, the date of the last dose and every immune side effect you had. The forward half lists the tests that continue, how often, and who orders each one.

Most people leave cancer treatment holding a stack of paper and no single page. Discharge summaries describe admissions. Prescriptions describe a month. Scan reports describe a day. None of them is the document you actually need in five years, when a doctor who has never met you is deciding whether your new symptom has anything to do with a drug you took in 2026. That is what a survivorship care plan is for — it is the record that tells any future doctor what was given and what to monitor.

What belongs in the document

Source: this list follows the way ASCO and NCCN describe survivorship care planning and follow-up after immune-related adverse events. There is no single mandated format in India, so hospitals differ. The headings matter more than the layout, and one page you will actually carry beats a file you will not.

Who Prepares a Survivorship Care Plan?

Your treating oncology team writes it, usually the medical oncologist who gave the immunotherapy. Anyone managing a lasting side effect contributes their section. In India no single format is mandated and no fixed moment triggers it, so the document is often not produced unless someone asks. Asking is normal.

It helps to know which person holds which part, because a plan assembled from four sources is stronger than one written from memory at a busy clinic. Nobody objects to writing it down. What usually happens is that the request is never made, the appointment ends, and the information stays scattered across a folder.

• The medical oncologist. Owns the treatment summary — drug, cycles, dates, response assessment and the immune side effects that were managed during treatment.
• The endocrinologist. Writes the hormone section where a gland was affected: current replacement, dose, monitoring interval and the sick-day rules that go with steroids.
• Any organ specialist involved. Gastroenterology, respiratory medicine, rheumatology or dermatology, if one of them treated a colitis, a pneumonitis, joint inflammation or a skin reaction.
• The day-care nursing team. Holds the infusion record — the actual dates of every cycle, which is the detail most often missing from a summary written afterwards.
• You. The only person present at every appointment, and the person who will still be holding the document long after the file is closed.

At CION, immunotherapy is given as a day-care infusion and the same medical oncology team reviews you afterwards; response-assessment imaging such as PET-CT is coordinated at partner imaging centres rather than owned by us. The monitoring half of the plan is set out test by test in which blood tests should continue after immunotherapy.

Why Does a Survivorship Care Plan Matter?

Because immunotherapy changes how you should be assessed for years, and nobody outside your cancer file knows it. Immune effects can begin months after the final dose. A surgeon, a dentist or a physician in another city needs the drug name and the date of your last dose early in the conversation, not after the tests come back.

The people this document protects are mostly people you have not met yet. That is the whole idea. It converts knowledge that currently lives in one hospital’s system, and in your memory, into something a stranger can act on in ten minutes.

• A new symptom is read correctly. Loose motions, breathlessness or joint pain in year two are interpreted differently once a doctor knows a checkpoint inhibitor was given and when.
• Monitoring does not lapse at handover. When oncology follow-up ends, the written list tells your physician exactly which tests continue — the commonest failure is three clinicians each assuming another is ordering them.
• Emergencies go better. If you take steroid replacement, an emergency department needs to know before you can explain it. The plan and a steroid card do that for you.
• Vaccination and infection decisions get easier. Your treatment history shapes that conversation — see vaccination and infection risk in long-term survivors.
• Later screening is planned, not improvised. Routine cancer screening still applies to you, and questions about second cancers after immunotherapy are easier to answer when the exposures are written down.
• Paperwork stops being a crisis. Insurance renewals, employment forms, a move to another city or a second opinion abroad all ask for the same facts. Family members funding care from overseas can work from the same page.

Surveillance after immunotherapy is clinician-directed. Your intervals come from your own records, not from a table on a website, and they are revised as your situation changes. The visit-by-visit shape of the first few years is covered in your follow-up schedule after immunotherapy.

How Do I Get a Survivorship Care Plan If Nobody Offered Me One?

Build the draft yourself, then have the clinical parts confirmed at your next review. Most of the facts are already in paper you hold. What you need from your team is verification and the forward half: which tests continue, at what interval, and who orders each one.

1. 1

   Collect what you already have

   Discharge summaries, day-care infusion records, prescriptions, scan reports and blood reports. The infusion records are the ones that carry the actual cycle dates.

2. 2

   Put the facts on one page

   Diagnosis and stage, drug name and class, number of cycles, first and last dose dates, side effects and how they were treated, and every medicine you take now.

3. 3

   Take it to your next review and ask two questions

   Is anything on this page wrong, and which tests should continue and how often. Those two questions turn your draft into a clinical document.

4. 4

   Get the monitoring list in writing, with owners

   Each test needs an interval and a named person responsible — oncology, endocrinology or your family physician. A verbal reassurance is worth very little two years later.

5. 5

   Give a copy to your family doctor

   They will be ordering most of the repeats once cancer surveillance ends. They can only do that if somebody tells them what is needed.

6. 6

   Keep it where you will actually find it

   A paper copy at home, a photo on your phone and a copy with a relative. Update it after every dose change, every new diagnosis and every hospital visit.

If a long steroid course was part of your treatment, ask whether bone protection belongs on the list as well — that decision is covered in bone health and long steroid exposure.

What a Survivorship Care Plan Cannot Tell You

It is a record and a schedule, not a forecast. Nothing in the document predicts whether the cancer returns, and a longer test list does not mean a worse situation. Long-term data on checkpoint inhibitors is still emerging, so parts of any plan are written to be revised rather than fixed.

This matters because survivorship paperwork is easy to over-read. People count the tests on the page and try to work out what the number means about them. It means nothing of the kind. The list reflects which organs were involved during treatment and which glands need replacement — that is all it is describing.

• No prognosis, in either direction. The plan does not estimate your chances and no one should read it as doing so. Questions about outcome belong in a conversation with your oncologist, about your own records.
• Intervals are clinician-directed and they move. Any schedule written today is reviewed at each visit. A gap that widens is a clinical judgement, not a verdict.
• Some long-term questions are genuinely unanswered. Modern checkpoint inhibitors have only been in wide clinical use since the mid-2010s. How immune side effects behave over decades, and what they mean for fertility or for later cancers, is still being studied — see what is known about second cancers.
• It does not replace being seen. A written plan makes appointments better; it does not make them optional, and new symptoms are assessed on their own merits whenever they appear.
• It is not a treatment recommendation. Nothing on this page tells you what should be done in your case. It describes a document, and what a good one contains.

Guidance from bodies such as NCCN, ASCO and ESMO on immune-related adverse events continues to be updated. A survivorship plan written this year is meant to be reviewed, and it is reasonable to ask at each visit whether anything on it has changed.

The Sections Most Survivorship Plans Point To Next

A plan is a table of contents for the years after treatment. The rows people ask about most are the ones below — later cancer risk, vaccination and infection, and bone health after steroids. If you want the general picture of how the treatment itself is given and reviewed, start at immunotherapy at CION Cancer Clinics.

The Record That Outlives the Treatment

A survivorship review puts the drug, the dates, the side effects and the monitoring schedule on one page you keep.